Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Clin Cancer Res. 2016 Jun 27;23(1):193–203. doi: 10.1158/1078-0432.CCR-16-0040

Figure 4. Tumor-specific T cells are primed in the draining lymph node.

Figure 4

(A) A20-bearing WT BALB/c mice (n = 5/group) were administered 100 μg of anti-mCD20 or hIgG on day 11. FTY720 was administered every two days starting on day 10 through the end of the experiment. (B-C) Eleven days after the Ab treatment, DLN cells (B) or splenocytes (C) were collected, and the IFN-γ ELISPOT assay was performed with medium or A20 cell restimulation. The mean ± SEM values are shown. Two-tailed Student’s t test was used for statistical analysis.